Acute coronary syndromes: should women receive less antithrombotic medication than men?
review · Level V
Where this comes from
- Record sourced from PubMed, PMID 15020498.
- Also identified by PMC identifier 1768185.
- No licence information is recorded for this record.
- Because redistribution is not established, this page shows the abstract only. Follow the links below for the full text.
Abstract
A recent meta-analysis of all randomised trials assessing the efficacy and safety of glycoprotein IIb/IIIa agents with acute coronary syndromes showed that there was a significant interaction with sex. Explaining this difference requires an analysis of whether it has any pathophysiological basis, whether antithrombotic medications are indeed less efficacious in women in different clinical situations, and whether there are any specific reasons that may have led to the provocative results of the meta-analysis.
Medical subject headings
- Coronary Disease
- Fibrinolytic Agents
- Platelet Glycoprotein GPIIb-IIIa Complex